首页 > 最新文献

Journal of Neuropathology and Experimental Neurology最新文献

英文 中文
Characterization of cerebellar amyloid-β deposits in Alzheimer disease. 阿尔茨海默病小脑淀粉样蛋白-β沉积的特征。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-01-19 DOI: 10.1093/jnen/nlad107
Gianluca Lopez, Shino D Magaki, Christopher Kazu Williams, Annlia Paganini-Hill, Harry V Vinters

Cerebellar amyloid-β (Aβ) plaques are a component of the diagnostic criteria used in Thal staging and ABC scoring for Alzheimer disease (AD) neuropathologic change. However, Aβ deposits in this anatomic compartment are unique and under-characterized; and their relationship with other pathological findings are largely undefined. In 73 cases of pure or mixed AD with an A3 score in the ABC criteria, parenchymal (plaques) and vascular (cerebral amyloid angiopathy [CAA]) cerebellar Aβ-42 deposits were characterized with respect to localization, morphology, density, and intensity. Over 85% of cases demonstrated cerebellar Aβ-42 parenchymal staining that correlated with a Braak stage V-VI/B3 score (p < 0.01). Among the 63 with cerebellar Aβ-42 deposits, a diffuse morphology was observed in 75% of cases, compact without a central dense core in 32%, and compact with a central dense core in 16% (all corresponding to plaques evident on hematoxylin and eosin staining). Cases with Purkinje cell (PC) loss showed higher proportions of PC layer Aβ-42 staining than cases without PC loss (88% vs 44%, p = 0.02), suggesting a link between Aβ-42 deposition and PC damage. Among all 73 cases, CAA was observed in the parenchymal vessels of 19% of cases and in leptomeningeal vessels in 44% of cases.

小脑淀粉样蛋白-β(Aβ)斑块是阿尔茨海默病(AD)神经病理学变化的Thal分期和ABC评分中使用的诊断标准的组成部分。然而,这一解剖区块中的 Aβ 沉积物是独特的,特征性不足;而且它们与其他病理结果的关系在很大程度上还未确定。在 73 例根据 ABC 标准进行 A3 评分的纯合性或混合性 AD 病例中,对小脑实质(斑块)和血管(脑淀粉样血管病 [CAA])Aβ-42 沉积的定位、形态、密度和强度进行了研究。超过85%的病例显示小脑Aβ-42实质染色与Braak V-VI/B3期评分相关(P<0.05)。
{"title":"Characterization of cerebellar amyloid-β deposits in Alzheimer disease.","authors":"Gianluca Lopez, Shino D Magaki, Christopher Kazu Williams, Annlia Paganini-Hill, Harry V Vinters","doi":"10.1093/jnen/nlad107","DOIUrl":"10.1093/jnen/nlad107","url":null,"abstract":"<p><p>Cerebellar amyloid-β (Aβ) plaques are a component of the diagnostic criteria used in Thal staging and ABC scoring for Alzheimer disease (AD) neuropathologic change. However, Aβ deposits in this anatomic compartment are unique and under-characterized; and their relationship with other pathological findings are largely undefined. In 73 cases of pure or mixed AD with an A3 score in the ABC criteria, parenchymal (plaques) and vascular (cerebral amyloid angiopathy [CAA]) cerebellar Aβ-42 deposits were characterized with respect to localization, morphology, density, and intensity. Over 85% of cases demonstrated cerebellar Aβ-42 parenchymal staining that correlated with a Braak stage V-VI/B3 score (p < 0.01). Among the 63 with cerebellar Aβ-42 deposits, a diffuse morphology was observed in 75% of cases, compact without a central dense core in 32%, and compact with a central dense core in 16% (all corresponding to plaques evident on hematoxylin and eosin staining). Cases with Purkinje cell (PC) loss showed higher proportions of PC layer Aβ-42 staining than cases without PC loss (88% vs 44%, p = 0.02), suggesting a link between Aβ-42 deposition and PC damage. Among all 73 cases, CAA was observed in the parenchymal vessels of 19% of cases and in leptomeningeal vessels in 44% of cases.</p>","PeriodicalId":16682,"journal":{"name":"Journal of Neuropathology and Experimental Neurology","volume":" ","pages":"72-78"},"PeriodicalIF":3.2,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10799296/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138805294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Whole-brain traumatic controlled cortical impact to the left frontal lobe: Magnetic resonance image-based texture analysis. 左额叶全脑受控皮层创伤性撞击:基于磁共振图像的纹理分析。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-01-19 DOI: 10.1093/jnen/nlad110
Saleh T Alanezi, Waleed M Almutairi, Michelle Cronin, Oliviero Gobbo, Shane M O'Mara, Declan Sheppard, William T O'Connor, Michael D Gilchrist, Christoph Kleefeld, Niall Colgan

This research assesses the capability of texture analysis (TA) derived from high-resolution (HR) T2-weighted magnetic resonance imaging to identify primary sequelae following 1-5 hours of controlled cortical impact mild or severe traumatic brain injury (TBI) to the left frontal cortex (focal impact) and secondary (diffuse) sequelae in the right frontal cortex, bilateral corpus callosum, and hippocampus in rats. The TA technique comprised first-order (histogram-based) and second-order statistics (including gray-level co-occurrence matrix, gray-level run length matrix, and neighborhood gray-level difference matrix). Edema in the left frontal impact region developed within 1 hour and continued throughout the 5-hour assessments. The TA features from HR images confirmed the focal injury. There was no significant difference among radiomics features between the left and right corpus callosum or hippocampus from 1 to 5 hours following a mild or severe impact. The adjacent corpus callosum region and the distal hippocampus region (s), showed no diffuse injury 1-5 hours after mild or severe TBI. These results suggest that combining HR images with TA may enhance detection of early primary and secondary sequelae following TBI.

本研究评估了从高分辨率(HR)T2加权磁共振成像中得出的纹理分析(TA)的能力,以确定大鼠左侧额叶皮层(局灶性撞击)受控皮层撞击轻度或重度创伤性脑损伤(TBI)1-5小时后的原发性后遗症,以及右侧额叶皮层、双侧胼胝体和海马的继发性(弥漫性)后遗症。TA技术包括一阶(基于直方图)和二阶统计(包括灰度级共现矩阵、灰度级运行长度矩阵和邻域灰度级差异矩阵)。左前额撞击区的水肿在 1 小时内出现,并持续了 5 小时的评估。HR 图像的 TA 特征证实了病灶损伤。在轻度或重度撞击后的 1 至 5 小时内,左右胼胝体或海马的放射组学特征没有明显差异。相邻的胼胝体区域和海马远端区域(s)在轻度或重度创伤性脑损伤 1-5 小时后未显示弥漫性损伤。这些结果表明,将 HR 图像与 TA 结合使用可增强对创伤后早期原发性和继发性后遗症的检测。
{"title":"Whole-brain traumatic controlled cortical impact to the left frontal lobe: Magnetic resonance image-based texture analysis.","authors":"Saleh T Alanezi, Waleed M Almutairi, Michelle Cronin, Oliviero Gobbo, Shane M O'Mara, Declan Sheppard, William T O'Connor, Michael D Gilchrist, Christoph Kleefeld, Niall Colgan","doi":"10.1093/jnen/nlad110","DOIUrl":"10.1093/jnen/nlad110","url":null,"abstract":"<p><p>This research assesses the capability of texture analysis (TA) derived from high-resolution (HR) T2-weighted magnetic resonance imaging to identify primary sequelae following 1-5 hours of controlled cortical impact mild or severe traumatic brain injury (TBI) to the left frontal cortex (focal impact) and secondary (diffuse) sequelae in the right frontal cortex, bilateral corpus callosum, and hippocampus in rats. The TA technique comprised first-order (histogram-based) and second-order statistics (including gray-level co-occurrence matrix, gray-level run length matrix, and neighborhood gray-level difference matrix). Edema in the left frontal impact region developed within 1 hour and continued throughout the 5-hour assessments. The TA features from HR images confirmed the focal injury. There was no significant difference among radiomics features between the left and right corpus callosum or hippocampus from 1 to 5 hours following a mild or severe impact. The adjacent corpus callosum region and the distal hippocampus region (s), showed no diffuse injury 1-5 hours after mild or severe TBI. These results suggest that combining HR images with TA may enhance detection of early primary and secondary sequelae following TBI.</p>","PeriodicalId":16682,"journal":{"name":"Journal of Neuropathology and Experimental Neurology","volume":" ","pages":"94-106"},"PeriodicalIF":3.2,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139074386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Persistence of Kii amyotrophic lateral sclerosis after the 2000s and its characteristic aging-related tau astrogliopathy. 2000 年代后 Kii 肌萎缩性脊髓侧索硬化症的持续存在及其与衰老相关的特征性 tau 星形胶质细胞病变。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-01-19 DOI: 10.1093/jnen/nlad113
Kazumi Tsuji, Yoshiaki Nakayama, Junko Taruya, Hidefumi Ito

Kii amyotrophic lateral sclerosis (ALS) is a unique disease that occurs in the southern portion of the Kii Peninsula and exhibits a dual pathology of TAR DNA-binding protein of 43 kDa (TDP-43) proteinopathy and tauopathy. The incidence of ALS in this region was very high in the 1960s, briefly decreased through the 1980s, but began increasing again after 2000 with a change of high-concentration geographic foci. It is unclear, however, whether the unique pathological features have changed along with the incidence changes. This study analyzed postmortem specimens from neuropathologically confirmed Kii ALS cases from the 1970s (n = 4) and those after 1999 (n = 12) from the southern Kii Peninsula or outside of the area. Our results confirm the continued occurrence of Kii ALS after 2000 in the southern Kii Peninsula and the preservation of disease-specific neuronal tau pathology, including the widespread occurrence throughout the brain and spinal cord, sparse neuropil threads, and predominance in superficial layers. Furthermore, we assessed the glial tau pathology of Kii and non-Kii ALS in accordance with the aging-related tau astrogliopathy classification method for the first time and detected a unique brainstem predominant appearance of gray matter aging-related tau astrogliopathy in Kii ALS cases, which may provide clues to pathogenetic mechanisms.

纪伊肌萎缩性脊髓侧索硬化症(ALS)是一种发生在纪伊半岛南部的独特疾病,表现出 TAR DNA 结合蛋白 43 kDa(TDP-43)蛋白病和牛磺酸蛋白病的双重病理特征。20 世纪 60 年代,该地区肌萎缩性脊髓侧索硬化症的发病率非常高,到 20 世纪 80 年代曾短暂下降,但 2000 年后,随着高发地域病灶的变化,发病率又开始上升。然而,目前还不清楚独特的病理特征是否随着发病率的变化而改变。本研究分析了 20 世纪 70 年代(4 例)和 1999 年以后(12 例)经神经病理学证实的纪伊肌萎缩性脊髓侧索硬化症病例的尸检标本,这些标本来自纪伊半岛南部或该地区以外。我们的研究结果证实,2000年后,Kii ALS继续在纪伊半岛南部发生,并保留了该病特有的神经元tau病理特征,包括广泛存在于整个大脑和脊髓、稀疏的神经髓丝、浅表层占主导地位等。此外,我们首次根据老化相关tau星形胶质细胞病变分类方法评估了纪伊和非纪伊ALS的胶质tau病变,发现纪伊ALS病例中灰质老化相关tau星形胶质细胞病变以脑干为主的独特表现,这可能为发病机制提供了线索。
{"title":"Persistence of Kii amyotrophic lateral sclerosis after the 2000s and its characteristic aging-related tau astrogliopathy.","authors":"Kazumi Tsuji, Yoshiaki Nakayama, Junko Taruya, Hidefumi Ito","doi":"10.1093/jnen/nlad113","DOIUrl":"10.1093/jnen/nlad113","url":null,"abstract":"<p><p>Kii amyotrophic lateral sclerosis (ALS) is a unique disease that occurs in the southern portion of the Kii Peninsula and exhibits a dual pathology of TAR DNA-binding protein of 43 kDa (TDP-43) proteinopathy and tauopathy. The incidence of ALS in this region was very high in the 1960s, briefly decreased through the 1980s, but began increasing again after 2000 with a change of high-concentration geographic foci. It is unclear, however, whether the unique pathological features have changed along with the incidence changes. This study analyzed postmortem specimens from neuropathologically confirmed Kii ALS cases from the 1970s (n = 4) and those after 1999 (n = 12) from the southern Kii Peninsula or outside of the area. Our results confirm the continued occurrence of Kii ALS after 2000 in the southern Kii Peninsula and the preservation of disease-specific neuronal tau pathology, including the widespread occurrence throughout the brain and spinal cord, sparse neuropil threads, and predominance in superficial layers. Furthermore, we assessed the glial tau pathology of Kii and non-Kii ALS in accordance with the aging-related tau astrogliopathy classification method for the first time and detected a unique brainstem predominant appearance of gray matter aging-related tau astrogliopathy in Kii ALS cases, which may provide clues to pathogenetic mechanisms.</p>","PeriodicalId":16682,"journal":{"name":"Journal of Neuropathology and Experimental Neurology","volume":" ","pages":"79-93"},"PeriodicalIF":3.2,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139403284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: D-2-hydroxyglutarate regulates human brain vascular endothelial cell proliferation and barrier function. 更正:D-2-羟基戊二酸调节人脑血管内皮细胞增殖和屏障功能。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-12-22 DOI: 10.1093/jnen/nlad095
{"title":"Correction to: D-2-hydroxyglutarate regulates human brain vascular endothelial cell proliferation and barrier function.","authors":"","doi":"10.1093/jnen/nlad095","DOIUrl":"10.1093/jnen/nlad095","url":null,"abstract":"","PeriodicalId":16682,"journal":{"name":"Journal of Neuropathology and Experimental Neurology","volume":" ","pages":"69"},"PeriodicalIF":3.2,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10746696/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72014583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sprouting of afferent and efferent inputs to pelvic organs after spinal cord injury. 脊髓损伤后盆腔器官传入和传出输入的萌芽。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-12-22 DOI: 10.1093/jnen/nlad108
Shunyi Zhao, Chuanxi Tang, Jeremy Weinberger, Dianshuai Gao, Shaoping Hou

Neural plasticity occurs within the central and peripheral nervous systems after spinal cord injury (SCI). Although central alterations have extensively been studied, it is largely unknown whether afferent and efferent fibers in pelvic viscera undergo similar morphological changes. Using a rat spinal cord transection model, we conducted immunohistochemistry to investigate afferent and efferent innervations to the kidney, colon, and bladder. Approximately 3-4 weeks after injury, immunostaining demonstrated that tyrosine hydroxylase (TH)-labeled postganglionic sympathetic fibers and calcitonin gene-related peptide (CGRP)-immunoreactive sensory terminals sprout in the renal pelvis and colon. Morphologically, sprouted afferent or efferent projections showed a disorganized structure. In the bladder, however, denser CGRP-positive primary sensory fibers emerged in rats with SCI, whereas TH-positive sympathetic efferent fibers did not change. Numerous CGRP-positive afferents were observed in the muscle layer and the lamina propria of the bladder following SCI. TH-positive efferent inputs displayed hypertrophy with large diameters, but their innervation patterns were sustained. Collectively, afferent or efferent inputs sprout widely in the pelvic organs after SCI, which may be one of the morphological bases underlying functional adaptation or maladaptation.

脊髓损伤(SCI)后,中枢神经系统和周围神经系统都会发生神经可塑性。虽然中枢神经的改变已被广泛研究,但盆腔内脏的传入和传出纤维是否会发生类似的形态学变化,目前还不得而知。利用大鼠脊髓横断模型,我们采用免疫组化方法研究了肾脏、结肠和膀胱的传入和传出神经支配。损伤后约 3-4 周,免疫染色显示酪氨酸羟化酶(TH)标记的节后交感神经纤维和降钙素基因相关肽(CGRP)免疫反应的感觉终端在肾盂和结肠中萌发。从形态上看,萌发的传入或传出突起呈现出杂乱无章的结构。然而,在膀胱中,脊髓损伤大鼠出现了更密集的 CGRP 阳性初级感觉纤维,而 TH 阳性交感传出纤维则没有变化。在膀胱损伤后的肌肉层和固有层观察到大量 CGRP 阳性传入。TH阳性传出输入显示肥大,直径变大,但其神经支配模式保持不变。总之,盆腔器官在脊髓损伤后广泛萌发传入或传出输入,这可能是功能适应或不适应的形态学基础之一。
{"title":"Sprouting of afferent and efferent inputs to pelvic organs after spinal cord injury.","authors":"Shunyi Zhao, Chuanxi Tang, Jeremy Weinberger, Dianshuai Gao, Shaoping Hou","doi":"10.1093/jnen/nlad108","DOIUrl":"10.1093/jnen/nlad108","url":null,"abstract":"<p><p>Neural plasticity occurs within the central and peripheral nervous systems after spinal cord injury (SCI). Although central alterations have extensively been studied, it is largely unknown whether afferent and efferent fibers in pelvic viscera undergo similar morphological changes. Using a rat spinal cord transection model, we conducted immunohistochemistry to investigate afferent and efferent innervations to the kidney, colon, and bladder. Approximately 3-4 weeks after injury, immunostaining demonstrated that tyrosine hydroxylase (TH)-labeled postganglionic sympathetic fibers and calcitonin gene-related peptide (CGRP)-immunoreactive sensory terminals sprout in the renal pelvis and colon. Morphologically, sprouted afferent or efferent projections showed a disorganized structure. In the bladder, however, denser CGRP-positive primary sensory fibers emerged in rats with SCI, whereas TH-positive sympathetic efferent fibers did not change. Numerous CGRP-positive afferents were observed in the muscle layer and the lamina propria of the bladder following SCI. TH-positive efferent inputs displayed hypertrophy with large diameters, but their innervation patterns were sustained. Collectively, afferent or efferent inputs sprout widely in the pelvic organs after SCI, which may be one of the morphological bases underlying functional adaptation or maladaptation.</p>","PeriodicalId":16682,"journal":{"name":"Journal of Neuropathology and Experimental Neurology","volume":" ","pages":"20-29"},"PeriodicalIF":3.2,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10746698/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138805295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alexander disease genetics: Beyond GFAP exon sequencing? 亚历山大病遗传学:超越GFAP外显子测序?
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-12-22 DOI: 10.1093/jnen/nlad100
Gert Cypers
{"title":"Alexander disease genetics: Beyond GFAP exon sequencing?","authors":"Gert Cypers","doi":"10.1093/jnen/nlad100","DOIUrl":"10.1093/jnen/nlad100","url":null,"abstract":"","PeriodicalId":16682,"journal":{"name":"Journal of Neuropathology and Experimental Neurology","volume":" ","pages":"65-66"},"PeriodicalIF":3.2,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138291227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diffuse hemispheric glioma with H3-3B G34R mutation: Expanding the spectrum of histone H3 genes in diffuse hemispheric glioma, H3 G34-mutant. H3-3B G34R突变的弥漫性半球脑胶质瘤:扩大弥漫性半球神经胶质瘤中组蛋白H3基因的谱,H3 G34突变。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-12-22 DOI: 10.1093/jnen/nlad089
Amir Nazem, Jonathan Lavezo, Zied Abdullaev, Kenneth Aldape, Martha Quezado, Patrick Joseph Cimino, Drew W Pratt, Robert B Jenkins, Cristiane M Ida
{"title":"Diffuse hemispheric glioma with H3-3B G34R mutation: Expanding the spectrum of histone H3 genes in diffuse hemispheric glioma, H3 G34-mutant.","authors":"Amir Nazem, Jonathan Lavezo, Zied Abdullaev, Kenneth Aldape, Martha Quezado, Patrick Joseph Cimino, Drew W Pratt, Robert B Jenkins, Cristiane M Ida","doi":"10.1093/jnen/nlad089","DOIUrl":"10.1093/jnen/nlad089","url":null,"abstract":"","PeriodicalId":16682,"journal":{"name":"Journal of Neuropathology and Experimental Neurology","volume":" ","pages":"58-60"},"PeriodicalIF":3.2,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11032700/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50161882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
H3K27-altered diffuse midline gliomas with MAPK pathway alterations: Prognostic and therapeutic implications. h3k27改变的弥漫性中线胶质瘤伴MAPK通路改变:预后和治疗意义
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-12-22 DOI: 10.1093/jnen/nlad103
Catherine Gestrich, Kristina Grieco, Hart G Lidov, Lissa C Baird, Katie P Fehnel, Kee Kiat Yeo, David M Meredith, Sanda Alexandrescu

Large-scale sequencing led to the identification of driver molecular alterations such as FGFR1 and BRAF in occasional diffuse midline gliomas (DMGs) H3K27-mutant but their significance has not been completely explored. We evaluated these associations in our institutional cohorts. We searched our archives for H3K2M7-mutant gliomas and analyzed the co-occurring genetic alterations. The demographics, clinical information, and pathology were reviewed. Oncoplots and Kaplan-Meier survival curves were generated with the maftools R package. We identified 81 patients (age range 2-68, median 26), of which 79 (97%) were DMGs, and 2 were glioneuronal tumors. The 2 glioneuronal tumors (1 with BRAF fusion and 1 BRAF-V600E-mutant) were removed from the outcome analysis. Four cases had BRAF V600E mutation, 12 had FGFR1 hotspot mutations, and one each had KRAS and NRAS pathogenic mutations. The most common correlating anatomic location was the brainstem for the BRAF group and thalamus for the FGFR1group. Follow-up ranged from 0 to 78 months, average 20.4 months. The overall survival in FGFR1- and BRAF V600E-mutant DMGs was not statistically improved when compared with those that were wildtype. However, the possibility of targeted therapy argues for comprehensive sequencing of H3K27-altered gliomas.

大规模测序鉴定了偶尔出现的弥漫性中线胶质瘤(dmg) h3k27突变体中的驱动分子改变,如FGFR1和BRAF,但其意义尚未完全探索。我们在我们的机构队列中评估了这些关联。我们检索了h3k2m7突变胶质瘤的档案,并分析了共同发生的遗传改变。回顾了人口统计学、临床资料和病理。肿瘤图和Kaplan-Meier生存曲线用maftools R包生成。我们确定了81例患者(年龄范围2-68岁,中位26岁),其中79例(97%)为dmg, 2例为神经胶质细胞肿瘤。2例胶质神经元肿瘤(1例BRAF融合,1例BRAF- v600e突变)从结果分析中剔除。BRAF V600E突变4例,FGFR1热点突变12例,KRAS和NRAS致病性突变各1例。BRAF组最常见的相关解剖位置是脑干,fgfr1组最常见的相关解剖位置是丘脑。随访0 ~ 78个月,平均20.4个月。与野生型相比,FGFR1-和BRAF v600e突变dmg的总生存率没有统计学上的提高。然而,靶向治疗的可能性要求对h3k27改变的胶质瘤进行全面测序。
{"title":"H3K27-altered diffuse midline gliomas with MAPK pathway alterations: Prognostic and therapeutic implications.","authors":"Catherine Gestrich, Kristina Grieco, Hart G Lidov, Lissa C Baird, Katie P Fehnel, Kee Kiat Yeo, David M Meredith, Sanda Alexandrescu","doi":"10.1093/jnen/nlad103","DOIUrl":"10.1093/jnen/nlad103","url":null,"abstract":"<p><p>Large-scale sequencing led to the identification of driver molecular alterations such as FGFR1 and BRAF in occasional diffuse midline gliomas (DMGs) H3K27-mutant but their significance has not been completely explored. We evaluated these associations in our institutional cohorts. We searched our archives for H3K2M7-mutant gliomas and analyzed the co-occurring genetic alterations. The demographics, clinical information, and pathology were reviewed. Oncoplots and Kaplan-Meier survival curves were generated with the maftools R package. We identified 81 patients (age range 2-68, median 26), of which 79 (97%) were DMGs, and 2 were glioneuronal tumors. The 2 glioneuronal tumors (1 with BRAF fusion and 1 BRAF-V600E-mutant) were removed from the outcome analysis. Four cases had BRAF V600E mutation, 12 had FGFR1 hotspot mutations, and one each had KRAS and NRAS pathogenic mutations. The most common correlating anatomic location was the brainstem for the BRAF group and thalamus for the FGFR1group. Follow-up ranged from 0 to 78 months, average 20.4 months. The overall survival in FGFR1- and BRAF V600E-mutant DMGs was not statistically improved when compared with those that were wildtype. However, the possibility of targeted therapy argues for comprehensive sequencing of H3K27-altered gliomas.</p>","PeriodicalId":16682,"journal":{"name":"Journal of Neuropathology and Experimental Neurology","volume":" ","pages":"30-35"},"PeriodicalIF":3.2,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138460516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors' response to: "Alexander disease genetics: Beyond GFAP exon sequencing?" 作者对“亚历山大病遗传学:超越GFAP外显子测序?”
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-12-22 DOI: 10.1093/jnen/nlad101
Abigail L Alexander, Swee Yang Lim, Lauren J Massingham, Oliver Phillips, Mary-Kathryn Chambers, John E Donahue
{"title":"Authors' response to: \"Alexander disease genetics: Beyond GFAP exon sequencing?\"","authors":"Abigail L Alexander, Swee Yang Lim, Lauren J Massingham, Oliver Phillips, Mary-Kathryn Chambers, John E Donahue","doi":"10.1093/jnen/nlad101","DOIUrl":"10.1093/jnen/nlad101","url":null,"abstract":"","PeriodicalId":16682,"journal":{"name":"Journal of Neuropathology and Experimental Neurology","volume":" ","pages":"67-68"},"PeriodicalIF":3.2,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138291228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive symptoms progress with limbic-predominant age-related TDP-43 encephalopathy stage and co-occurrence with Alzheimer disease. 认知症状进展与边缘显性年龄相关TDP-43脑病阶段并与阿尔茨海默病共发。
IF 3.2 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-12-22 DOI: 10.1093/jnen/nlad098
Satomi Hiya, Carolina Maldonado-Díaz, Jamie M Walker, Timothy E Richardson

Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is a neuropathologic entity characterized by transactive response DNA-binding protein of 43-kDa (TDP-43)-immunoreactive inclusions that originate in the amygdala and then progress to the hippocampi and middle frontal gyrus. LATE-NC may mimic Alzheimer disease clinically and often co-occurs with Alzheimer disease neuropathologic change (ADNC). This report focuses on the cognitive effects of isolated and concomitant LATE-NC and ADNC. Cognitive/neuropsychological, neuropathologic, genetic, and demographic variables were analyzed in 28 control, 31 isolated LATE-NC, 244 isolated ADNC, and 172 concurrent LATE-NC/ADNC subjects from the National Alzheimer's Coordinating Center. Cases with LATE-NC and ADNC were significantly older than controls; cases with ADNC had a significantly higher proportion of cases with at least one APOE ε4 allele. Both LATE-NC and ADNC exhibited deleterious effects on overall cognition proportional to their neuropathological stages; concurrent LATE-NC/ADNC exhibited the worst overall cognitive effect. Multivariate logistic regression analysis determined an independent risk of cognitive impairment for progressive LATE-NC stages (OR 1.66; p = 0.0256) and ADNC levels (OR 3.41; p < 0.0001). These data add to the existing knowledge on the clinical consequences of LATE-NC pathology and the growing literature on the effects of multiple concurrent neurodegenerative pathologies.

边缘显性年龄相关性TDP-43脑病神经病理改变(LATE-NC)是一种神经病理实体,其特征是43-kDa (TDP-43)的dna结合蛋白-免疫反应包涵体的交互反应,起源于杏仁核,然后进展到海马和额叶中回。晚期nc在临床上可能与阿尔茨海默病相似,并且经常与阿尔茨海默病神经病理改变(ADNC)共同发生。本报告的重点是孤立和合并晚期nc和ADNC的认知影响。对来自国家阿尔茨海默病协调中心的28例对照、31例分离的LATE-NC、244例分离的ADNC和172例并发的LATE-NC/ADNC患者的认知/神经心理学、神经病理学、遗传学和人口统计学变量进行分析。LATE-NC和ADNC患者年龄明显大于对照组;ADNC患者携带至少一个APOE ε4等位基因的比例显著高于ADNC患者。晚期nc和ADNC对整体认知的有害影响与其神经病理分期成正比;并发的LATE-NC/ADNC表现出最差的整体认知效果。多因素logistic回归分析确定了进行性nc晚期认知功能障碍的独立风险(OR 1.66;p = 0.0256)和ADNC水平(OR 3.41;p
{"title":"Cognitive symptoms progress with limbic-predominant age-related TDP-43 encephalopathy stage and co-occurrence with Alzheimer disease.","authors":"Satomi Hiya, Carolina Maldonado-Díaz, Jamie M Walker, Timothy E Richardson","doi":"10.1093/jnen/nlad098","DOIUrl":"10.1093/jnen/nlad098","url":null,"abstract":"<p><p>Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is a neuropathologic entity characterized by transactive response DNA-binding protein of 43-kDa (TDP-43)-immunoreactive inclusions that originate in the amygdala and then progress to the hippocampi and middle frontal gyrus. LATE-NC may mimic Alzheimer disease clinically and often co-occurs with Alzheimer disease neuropathologic change (ADNC). This report focuses on the cognitive effects of isolated and concomitant LATE-NC and ADNC. Cognitive/neuropsychological, neuropathologic, genetic, and demographic variables were analyzed in 28 control, 31 isolated LATE-NC, 244 isolated ADNC, and 172 concurrent LATE-NC/ADNC subjects from the National Alzheimer's Coordinating Center. Cases with LATE-NC and ADNC were significantly older than controls; cases with ADNC had a significantly higher proportion of cases with at least one APOE ε4 allele. Both LATE-NC and ADNC exhibited deleterious effects on overall cognition proportional to their neuropathological stages; concurrent LATE-NC/ADNC exhibited the worst overall cognitive effect. Multivariate logistic regression analysis determined an independent risk of cognitive impairment for progressive LATE-NC stages (OR 1.66; p = 0.0256) and ADNC levels (OR 3.41; p < 0.0001). These data add to the existing knowledge on the clinical consequences of LATE-NC pathology and the growing literature on the effects of multiple concurrent neurodegenerative pathologies.</p>","PeriodicalId":16682,"journal":{"name":"Journal of Neuropathology and Experimental Neurology","volume":" ","pages":"2-10"},"PeriodicalIF":3.2,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10746699/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134649167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Neuropathology and Experimental Neurology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1